Melevodopa (hydrochloride)
Melevodopa hydrochloride is an effervescent Levodopa (HY-N0304) prodrug. Levodopa is an orally active metabolic precursor of neurotransmitters dopamine and has anti-allodynic effects and the potential for Parkinson's disease[1]
Product Specifications
CAS Number
[1421-65-4]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Dopamine Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/melevodopa-hydrochloride.html
Purity
99.71
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
N[C@@H](CC1=CC=C(O)C(O)=C1)C(OC)=O.[H]Cl
Molecular Formula
C10H14ClNO4
Molecular Weight
247.68
Precautions
H302, H315, H319, H335
References & Citations
[1]Hickey P, et al. Available and emerging treatments for Parkinson's disease: a review. Drug Des Devel Ther. 2011;5:241-54.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
DDX11, CT (DDX11, CHL1, CHLR1, KRG2, Probable ATP-dependent RNA helicase DDX11, CHL1-related protein 1, DEAD/H box protein 11, Keratinocyte growth factor-regulated gene 2 protein) (Biotin) discontinued
